Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
07/16/2009 | CA2707441A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
07/15/2009 | EP2078013A1 Novel crystalline modification of 4- (n-methyl-2-chloro-5-pyridylmethylamino) -2,5-dihydrofuran-2-one |
07/15/2009 | EP2078012A2 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
07/15/2009 | EP2078010A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
07/15/2009 | EP2077997A1 Pyridazine derivatives |
07/15/2009 | EP2077841A1 Novel substituted pyrimidines as cysteine protease inhibitors |
07/15/2009 | EP1844039B1 5-substituted quinoline and isoquinoline derivatives, a method for the production thereof and their use as antiphlogistics |
07/15/2009 | EP1426365B1 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same |
07/15/2009 | CN101484446A Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and agents containing said compounds |
07/15/2009 | CN101484445A An enantioselective synthesis of pyrrolidine-substituted flavones |
07/15/2009 | CN100513407C Tricyclic delta-opioid modulators |
07/15/2009 | CN100513397C Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors |
07/15/2009 | CN100513387C Novel dibenzo[B,F]oxepine-10-carboxamides and pharmaceutical uses thereof |
07/14/2009 | US7560569 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity |
07/14/2009 | US7560565 Method for preparing derivatives of 3-hydroxypicolinic acid |
07/14/2009 | US7560563 Process for producing 2-substituted pyridine derivative |
07/14/2009 | US7560554 fac-Bis[2-(2-pyridinyl- kappa N)phenyl- kappa C]-[2-(2-pyridinyl- kappa N)(5-formylphenyl)- kappa C]-iridium(III); phosphorescence emitters; organic light-emitting diode, an organic integrated circuit, an organic field effect transistor, an organic thin-film transistor, an organic solar cell |
07/14/2009 | US7560546 Tyrosine kinase inhibitors |
07/14/2009 | US7560480 Alkyl-containing 5-acylindolinones, the preparation thereof and their use as medicaments |
07/14/2009 | US7560467 Indazolo-tetrahydropyrimidine-carboxamide derivative kinase inhibitors |
07/14/2009 | US7560466 N4-(2,2-Dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-N2-(3-chloro-4-methoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE (Fc epsilon RI) and IgG (Fc gamma RI) antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis |
07/14/2009 | US7560464 (5-Methoxy-2-pyridin-2-yl-pyrimidin-4-yl)-(5-pyrrolidin-1-yl-pyridin-2-yl)-amine; SK channel modulators (SK=small conductance calcium activated potassium channels); antiepileptic agents; seizures; learning enhancement; cognition activators; mood/psychotic disorders; antidepressants; Parkinson's disease |
07/14/2009 | US7560463 Diaryl ethers as opioid receptor antagonists |
07/14/2009 | US7560462 Compounds useful for inhibiting CHK1 |
07/14/2009 | US7560460 2-[(4-Chlorophenyl)methyl]-1-(4- {2-[(cyclopropylmethyl)-(methylsulfonyl)amino]phenyl }-piperazinyl) -4-(2-(1,2,3,4-tetrahydroisoquinolyl))butane-1,4-dione; obesity/dietietics; melanocortin receptor angonists; prophylaxis/treatment of diseases involving activation of the melanocortin recepetors (MCR) |
07/14/2009 | US7560458 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
07/14/2009 | US7560435 Therapeutic use of riboside of 5-aminoimidazole-4-carboxamide (acadesine) |
07/14/2009 | US7560124 Photochromic compounds |
07/14/2009 | CA2533369C Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
07/14/2009 | CA2403321C Amide compounds and use thereof |
07/10/2009 | WO2008083367A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
07/10/2009 | CA2710234A1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
07/09/2009 | WO2009086041A1 Herbicidal pyridazinone derivatives |
07/09/2009 | WO2009085584A1 6h-dibenz0 [b, e] oxepine derived nonsteroidal mineralocorticoid receptor antagonists |
07/09/2009 | WO2009085344A2 Dibenzothiophene, dibenzofuran and/or carbazole-containing materials in phosphorescent light emitting diodes |
07/09/2009 | WO2009084773A2 Preparation process useful in synthesis of atorvastatin |
07/09/2009 | WO2009084695A1 2-aminoquinazoline derivative |
07/09/2009 | WO2009084655A1 METHOD FOR PRODUCING 4'-ETHYNYL d4T |
07/09/2009 | WO2009083581A1 Carboxamide compounds and their use as calpain inhibitors |
07/09/2009 | WO2009083553A1 Azine compounds as glucokinase activators |
07/09/2009 | WO2009083526A1 Novel compounds |
07/09/2009 | WO2009062874A3 Benzimidazole derivatives and their use as fxr agonists |
07/09/2009 | US20090176989 Processes for producing cycloalkylcarboxamido-pyridine benzoic acids |
07/09/2009 | US20090176980 4-[4-Isopropoxy-5-(5-isopropyl-2-methyl-phenoxymethyl)-6-methyl-pyridin-2-yl]-5-isopropyl-1H-indazole; binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology |
07/09/2009 | US20090176973 Thrombopoietin mimetics |
07/09/2009 | US20090176859 Cathepsin cysteine protease inhibitors |
07/09/2009 | US20090176856 Muscarinic receptor antagonists |
07/09/2009 | US20090176854 N-[4-((1S)-1-{3-(3,5-Dichlorophenyl)-5-[6-(trifluoromethoxy)-2-naphthyl]-1H-pyrazol-1-yl}ethyl)benzoyl]- beta -alanine; type 2 diabetes, hyperglycemia, or insulin resistance |
07/09/2009 | US20090176840 Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
07/09/2009 | US20090176837 Compounds with activity at retinoic acid receptors |
07/09/2009 | US20090176836 3-{[(3-amino-3-benzyltetrahydrofuran-2-yl)oxy]methyl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[(methylsulfonyl)(propyl)amino]benzamide, used for preventing the formation of insoluble amyloid proteins |
07/09/2009 | US20090176828 treating pain with minimal cardiovascular and/or sedatory activity side effects;hypertension, depression, glaucoma, elevated intraocular pressure, ischemic neuropathies, optic neuropathy, diabetic retinopathy, stroke, withdrawal symptoms, obsessive compulsive disorder, obesity, diarrhea, nasal congestion |
07/09/2009 | US20090176806 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer |
07/09/2009 | US20090176799 Phosphodiesterase 4 inhibitors |
07/09/2009 | US20090176793 3-(l,3-BENZODIOXOL-5-YL)-6-(4-CYCLOPROPYLPIPERAZIN-l-YL)-PYRIDAZINE, ITS SALTS AND SOLVATES AND ITS USE AS HISTAMINE H3 RECEPTOR ANTAGONIST |
07/09/2009 | US20090176780 Nitrogenous heterocyclic compounds |
07/09/2009 | US20090176774 Compounds and methods of use |
07/09/2009 | US20090176771 Gyrase inhibitors and uses thereof |
07/09/2009 | US20090176767 Biphenyl-2-ylcarbamic Acid 1-(2-{5-[2-(4-Hydroxyphenyl)ethylamino]pentylcarbamoyl}ethyl)piperidin-4-yl Ester, used for the treatment of respiratory system disorders such as chronic obstructive pulmonary disease and asthma |
07/09/2009 | US20090176764 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
07/09/2009 | US20090176746 4'-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-3'-hydroxybiphenyl-4-carboxylic acid; Promotes thrombopoiesis and megakaryocytopoiesis |
07/09/2009 | US20090176730 N4-acylcytosine nucleosides for treatment of viral infections |
07/09/2009 | US20090176307 Compounds, Compositions and Methods |
07/09/2009 | US20090176279 Bioreactive agents |
07/09/2009 | US20090175888 Methods of treating cancer with an antibody-drug conjugate |
07/09/2009 | US20090174312 Tetraphenylnaphalene Derivatives and Organic Light Emitting Diode Using the Same |
07/09/2009 | CA2710903A1 Carboxamide compounds and their use as calpain inhibitors |
07/09/2009 | CA2707520A1 Herbicidal pyridazinone derivatives |
07/08/2009 | EP2077265A1 Salt of sulfinylbenzimidazole compound, and crystal and amorphous form thereof |
07/08/2009 | EP2076504A2 Dichroic-photochromic compounds and devices |
07/08/2009 | EP2076503A2 C-phenyl glycitol compound for the treatment of diabetes |
07/08/2009 | EP2076499A2 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators |
07/08/2009 | EP2076495A1 Quinoline derivatives with 5-ht-binding properties |
07/08/2009 | EP2076260A1 N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same |
07/08/2009 | EP2076128A2 Protein kinase inhibitors and methods for using thereof |
07/08/2009 | EP1592686B1 Gyrase inhibitors and uses thereof |
07/08/2009 | CN101479260A Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them |
07/08/2009 | CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
07/08/2009 | CN100509807C Indazole derivative for pestide |
07/08/2009 | CN100509805C 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
07/08/2009 | CN100509804C N-substituted piperidine derivatives as serotonin receptor agents |
07/08/2009 | CN100509803C Extractive of total benzofuran of benzoin plants, prepn. method and use thereof |
07/08/2009 | CN100509801C HIV inhibiting pyrimidines derivatives |
07/08/2009 | CN100509794C Therapeutic heterocyclic compounds |
07/08/2009 | CN100509791C Compound and use of the compound as glycine transport inhibitors |
07/08/2009 | CN100509790C Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
07/08/2009 | CN100509774C Acylsulfonamides as inhibitors of steroid sulfatase |
07/07/2009 | US7557210 Antiinflamamtory agents |
07/07/2009 | US7557208 5-hydroxy-7H-benzo[C]fluorene derivatives: 7,7-dimethyl-5-hydroxy-9-morpholino-7H-benzo[C]fluorene; intermediates for preparing indeno-fused naphthopyrans exhibiting reversible photochromism |
07/07/2009 | US7557137 Gamma-lactams as beta-secretase inhibitors |
07/07/2009 | US7557130 Bicyclic heteroaromatic alanines |
07/07/2009 | US7557129 Cyanopyridine derivatives useful in the treatment of cancer and other disorders |
07/07/2009 | US7557125 Fab I inhibitors |
07/07/2009 | US7557124 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
07/07/2009 | US7556797 Absorption, fluorescence of light; diagnosis of kidney, heart diseases |
07/07/2009 | CA2486101C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
07/07/2009 | CA2461510C Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
07/07/2009 | CA2450033C Viral polymerase inhibitors |
07/07/2009 | CA2378834C Pyrazinones, compositions containing such compounds |
07/02/2009 | WO2009082526A2 Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation |